Inferring statin-induced gene regulatory relationships in primary human hepatocytes
Author(s) -
Adrian Schröder,
Johannes Wollnik,
Clemens Wrzodek,
Andreas Dräger,
Michael Bonin,
Oliver Burk,
Maria Thomas,
Wolfgang E. Thasler,
Ulrich M. Zanger,
Andreas Zell
Publication year - 2011
Publication title -
bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.599
H-Index - 390
eISSN - 1367-4811
pISSN - 1367-4803
DOI - 10.1093/bioinformatics/btr416
Subject(s) - atorvastatin , computational biology , statin , transcription factor , drug discovery , microarray analysis techniques , microarray , gene , gene expression , biology , hmg coa reductase , bioinformatics , drug , cyp3a4 , reductase , pharmacology , cytochrome p450 , genetics , enzyme , biochemistry
Statins are the most widely used cholesterol-lowering drugs. The primary target of statins is HMG-CoA reductase, a key enzyme in cholesterol synthesis. However, statins elicit pleitropic responses including beneficial as well as adverse effects in the liver or other organs. Today, the regulatory mechanisms that cause these pleiotropic effects are not sufficiently understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom